tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KTTA Stock Latest News

Pasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice
Company AnnouncementsPasithea Therapeutics Receives Nasdaq Minimum Bid Price Notice
2d ago
8K
KTTA
Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization
PremiumCompany Announcements
Pasithea Therapeutics Shareholders Approve Expanded Equity Authorization
26d ago
8K
KTTA
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway
PremiumRatings
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway
1M ago
KTTA
Pasithea Therapeutics provides updated timeline on PAS-004 programs
PremiumThe Fly
Pasithea Therapeutics provides updated timeline on PAS-004 programs
1M ago
KTTA
Pasithea Therapeutics Regains Nasdaq Compliance
PremiumCompany Announcements
Pasithea Therapeutics Regains Nasdaq Compliance
2M ago
8K
KTTA
Pasithea Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyPasithea Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
KTTA
3 Penny Stocks to Watch Now, 12/2/25
Premium
Market News
3 Penny Stocks to Watch Now, 12/2/25
3M ago
ADTX
BEAM
Pasithea Therapeutics Completes $60M Public Offering
Premium
Company Announcements
Pasithea Therapeutics Completes $60M Public Offering
3M ago
8K
KTTA
Pasithea Therapeutics prices 80M shares at 75c in public offering
PremiumThe Fly
Pasithea Therapeutics prices 80M shares at 75c in public offering
3M ago
KTTA
3 Penny Stocks to Watch Now, 11/27/25
PremiumMarket News
3 Penny Stocks to Watch Now, 11/27/25
3M ago
AMBR
KTTA
Pasithea Therapeutics Reports Positive Phase 1 Data for PAS-004
PremiumCompany Announcements
Pasithea Therapeutics Reports Positive Phase 1 Data for PAS-004
3M ago
8K
KTTA
Pasithea Therapeutics announces $1M award by ALS Association
PremiumThe Fly
Pasithea Therapeutics announces $1M award by ALS Association
3M ago
KTTA
Pasithea Therapeutics completes cohort 7 in Phase 1 trial of PAS-004
PremiumThe FlyPasithea Therapeutics completes cohort 7 in Phase 1 trial of PAS-004
3M ago
KTTA
Pasithea says tablet PK exposure increases proprtionally with dose increase
Premium
The Fly
Pasithea says tablet PK exposure increases proprtionally with dose increase
3M ago
KTTA
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
3M ago
C
HD
Why Is Pasithea Therapeutics Stock (KTTA) Down Today?
PremiumMarket News
Why Is Pasithea Therapeutics Stock (KTTA) Down Today?
3M ago
KTTA
Pasithea Therapeutics announces interim data from PAS-004 trial
PremiumThe Fly
Pasithea Therapeutics announces interim data from PAS-004 trial
3M ago
KTTA
Pasithea announces activation of trial site at UAB for study of PAS-004
PremiumThe Fly
Pasithea announces activation of trial site at UAB for study of PAS-004
4M ago
KTTA
Pasithea Therapeutics Opens New Trial Site for PAS-004
PremiumCompany Announcements
Pasithea Therapeutics Opens New Trial Site for PAS-004
4M ago
8K
KTTA
Pasithea Therapeutics Aligns Executive Compensation Strategy
PremiumCompany AnnouncementsPasithea Therapeutics Aligns Executive Compensation Strategy
4M ago
8K
KTTA
Pasithea Therapeutics’ PAS-004 Trial: A Step Forward in NF1 Treatment
Premium
Company Announcements
Pasithea Therapeutics’ PAS-004 Trial: A Step Forward in NF1 Treatment
4M ago
KTTA
Pasithea Therapeutics’ Promising Phase 1 Study on PAS-004 for Advanced Solid Tumors
Premium
Company Announcements
Pasithea Therapeutics’ Promising Phase 1 Study on PAS-004 for Advanced Solid Tumors
4M ago
KTTA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >